Orient Pharma Revenue

In the year 2025, Orient Pharma had annual revenue of 1.40B TWD with 14.52% growth. Orient Pharma had revenue of 441.81M in the quarter ending December 31, 2025, with 38.40% growth.

Revenue

1.40B

Revenue Growth

+14.52%

P/S Ratio

4.20

Revenue / Employee

8.09M

Employees

173

Market Cap

5.88B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	177.56M	14.52%
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SCI Pharmtech	1.34B
LIWANLI Innovation	125.54M
Formosa Laboratories	4.85B
Easywell Biomedicals	597.41M
Orient EuroPharma	4.60B
Merdury Biopharmaceutical	246.00K
Alar Pharmaceuticals	2.75M
Standard Chemical & Pharmaceutical	7.02B

Revenue Rankings